12.12.2023 • News

Syensqo Launched on Euronext

Yesterday, Syensqo announced the listing of its shares on Euronext Brussels and Euronext Paris. After completing the spin-off from Solvay, the listing marks a historical milestone as the company embarks on an innovation-driven journey.

Syensqo addresses environmental and social challenges through electrification, lightweighting, connectivity, resource efficiency, and transitioning towards a net-zero economy.

Upon listing, Syensqo has 105,876,417 ordinary shares in issue, each carrying one voting right. The Syensqo share price started its journey at a value of € 90 at market open (9.00 am CET), which corresponds to a market capitalization of € 9.53 billion.

“We are thrilled to begin our journey on Euronext, With SYENS in both our name and ticker, we are now officially launched as a science company, one of the largest publicly traded specialty companies in the world. Born from a rich heritage, vision and track record of science, innovation and disruption, we are uniquely exposed to secular megatrends that will accelerate our long-term growth and are dedicated to having a meaningful impact on our planet," commented Ilham Kadri, CEO of Syensqo.

Syensqo is expected to be included in major stock market indices such as BEL20, Stoxx Europe 600, MSCI Europe, FTSE Russell, among others, subject to the timing of each individual index review.

Syensqo recently launched on Euronext. © Syensqo
Syensqo recently launched on Euronext. © Syensqo

Company

Syensqo

rue de la Fusée 98
B-1130 Brussels
Belgium

Company contact







Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.